Biotech Growth Trust plc (The) (BIOG) Ordinary 25p
10.00p
(0.80%)
- Add to watchlist
- Create an alert
- This stock can be held in a
10.00p
(0.80%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
10.00p
(0.80%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
1,242.00p
1,258.00p
1,750.00p
1,282.91
1,248.00p
1,235.08p
1,160.00p
-2.72%
10.00p (0.81%) Previous:
10.00p
82,835
n/a
GBX
Price
-
Net Asset Value (NAV)
Performance
| 1 week 1W | 1.62% | 1 year 1Y | 0% |
|---|---|---|---|
| 1 month 1M | 10.14% | 2 years 2Y | 64.23% |
| 3 months 3M | 5.7% | 3 years 3Y | 54.17% |
| 6 months 6M | 24.49% | 5 years 5Y | 73.04% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Trust Basics
| Benchmark: | NASDAQ Biotechnology TR GBP |
|---|---|
| Annual management charge: | n/a |
| Performance fee: | Yes |
| Ongoing charge: | 1.28% |
| Dividend yield: | n/a |
| Dividend frequency: | None |
| Total assets: | £587m |
| Gross gearing: | 109% |
| Market capitalisation:Market cap.: | £521m |
| Shares in issue: | 41.73 million |
| Legal structure | Closed Ended Investment Company |
| Domicile: | United Kingdom |
| ISIN | GB0000385517 |
Dividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
To buy shares in , you'll need to have an account.
Try our handy filter to explore the different options.
Ready to invest?
To invest in , you'll need to open an account.
Try our handy filter to find which one suits you best.
Important Documents
Objective
NET ASSET VALUE (NAV)
| Estimated NAV: | 1,282.91 |
|---|---|
| Latest actual NAV: | 1,280.46 |
| Latest actual NAV date: | 4 August 2021 |
| Premium/Discount: | -2.72% |
| 12m average Premium/Discount: | -0.16% |
| NAV frequency: | Daily |
Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.
| Security | Weight |
|---|---|
| Vertex Pharmaceuticals Inc | 6.13% |
| Neurocrine Biosciences Inc | 3.76% |
| Horizon Therapeutics plc Ordinary Shares | 3.75% |
| Immunogen Inc | 3.28% |
| Guardant Health Inc | 3.05% |
| Alexion Pharmaceuticals Inc | 2.99% |
| Aptose Biosciences Inc | 2.84% |
| Keros Therapeutics Inc | 2.84% |
| Amgen Inc | 2.58% |
| Biogen Inc | 2.58% |
| Sector | Weight |
|---|---|
| Healthcare | 95.29% |
| Country | Weight |
|---|---|
| United States | 69.10% |
| China | 10.01% |
| Canada | 8.03% |
| United Kingdom | 2.95% |
| Switzerland | 2.72% |
| Cayman Islands | 2.52% |
| Singapore | 0.96% |
| France | 0.89% |
| Germany | 0.47% |
| Denmark | 0.19% |
Key Dates
| Launch date: | 23 June 1997 |
|---|---|
| Financial year end: | March |
| Next AGM: | July 2022 |
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.